Font: Financial Modeling Prep • Aug 27, 2026
Sociedad Química y Minera de Chile (NYSE:SQM) is a Chilean chemical company and one of the world's largest producers of lithium. The company's main activities involve mining and processing resources like lithium, iodine, and specialty plant nutrients. It operates in a market with growing demand, driven by the electric vehicle (EV) industry.
On August 26, 2026, the investment firm Citigroup upgraded its rating on SQM to "Buy" from its previous "Neutral" rating. At the time of this upgrade, the stock price was $78.28. This change in rating suggests a more positive outlook on the company's future performance from the investment firm.
The upgrade follows a period of strong financial performance. For the second quarter of 2026, SQM reported a net income of $660.00 million. This represents a significant 646.4% increase from the $88.40 million earned in the same quarter of 2025, showing substantial profit growth and operational efficiency.
Looking at the first six months of 2026, the company's net income reached $1.02 billion, a 353.5% rise from the prior year. Total revenues also increased by 103.4% to $4.23 billion. This performance is supported by a gross profit of $2.04 billion, which is 48.2% of revenues.
The company's outlook appears favorable, with an attractive forward price-to-earnings (P/E) ratio of 11. A lower P/E can indicate that a stock may be undervalued relative to its earnings. SQM also lifted its 2026 lithium demand outlook, as highlighted by Reuters, due to expected growth in electric vehicle (EV) adoption.
|
VNRX§>
VolitionRX Ltd
|
$0.50
47.70%
|
|
NVDA§>
NVIDIA Corporation
|
$227.98
8.74%
|
|
RITR§>
Reitar Logtech Holdings Limited Ordinary shares
|
$0.10
11.75%
|
|
CELU§>
Celularity Inc.
|
$2.10
138.53%
|
|
NVD§>
GraniteShares 2x Short NVDA Daily ETF
|
$3.73
-16.93%
|
|
WKSP§>
Worksport Ltd.
|
$0.63
23.53%
|
|
MERC§>
Mercer International Inc.
|
$0.39
-5.57%
|
|
INTC§>
Intel Corp.
|
$92.09
4.36%
|
|
NCPL§>
Netcapital Inc.
|
$0.54
7.55%
|
|
PPCB§>
Propanc Biopharma, Inc.
|
$2.23
108.41%
|